Severe 5-fluorouracil-induced toxicity due to decreased dihydropyrimidine dehydrogenase activity: Report of a patient survival and urinary pyrimidine and dihydropyrimidine levels

International Journal of Clinical Oncology

Volumn 4, Issue 4, 1999, Pages 241-243

  Dobashi, Kazuyoshi ^a   Ohe, Eiichi ^a   Yamaguchi, Kazuko ^a   Takeshita, Shigeki ^a   Ayabe, Takuya ^a   Miyazaki, Michio ^a   Kidouchi, Kiyoshi ^b   Sumi, Satoshi ^c   Okinaga, Shoichi ^a   Mori, Hiroyuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b Nagoya City Higashi General Hospital   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

5 Fluorouracil induced toxicity; Breast cancer; Dihydropyrimidine; Dihydropyrimidine dehydrogenase (DPD); Pyrimidine

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; DIHYDROURACIL; DOXIFLURIDINE; FLUOROURACIL; PYRIMIDINE; PYRIMIDINE DERIVATIVE; THYMINE; THYMINE DERIVATIVE; URACIL;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PYRIMIDINE METABOLISM; SCREENING TEST; SURVIVAL; URINE LEVEL;

EID: 0032867125     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470050061     Document Type: Article

References (8)

1. Tuchman M, Stoeckeler JS, Kiang DT, et al. (1985) Familial pyrimidinemia and pyrimidiuria associated with severe fluorouracil toxicity. New Engl J Med 313:245-249
2. Gonzalez FJ, Fernandez-Salguero P (1995) Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency. Trends Pharmacol Sci 16:325-327
3. Odagiri H, Ichihara S, Seruma E, et al. (1988) Determinaton of 5-fluorouracil in plasma and liver after oral administration of 5′-deoxy-fluorouridine using gas chromatography-mass spectrometry. J Pharmacobio-Dyn 11:234-240
4. Harris BE, Song R, Soong S, Diasio RB (1990) Relationship between dihydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res 50:197-201
5. Diasio RB, Beavers TY, Carpenter JT (1988) Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical bases for familial pyrimidinemia and severe 5-fluorouuracil-induced toxicity. J Clin Invest 81:47-51
6. Hayashi K, Kidouchi K, Sumi S, et al. (1996) Possible prediction of adverse reactions to pyrimidine chemotherapy from urinary pyrimidine levels and a case of asymptomatic adult dihydropyrimidiniuria. Clin Cancer Res 2:1937-1941
7. Sumi S, Kidouchi K, Ohba S, Wada Y (1995) Automated screening system for purine and pyrimidine metabolism disorders using high performance liquid chromatography. J Chromatogr 672:233-239
8. Elienne MC, Lagrange JL, Dassonville O, et al. (1994) Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol 12:2248-2253